Genetic sequencing
( DrugBank: - / KEGG DRUG: - )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
40 | Takayasu arteritis | 1 |
231 | Alpha-1-antitrypsin deficiency | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
298 | Hereditary pancreatitis | 1 |
40. Takayasu arteritis
Clinical trials : 30 / Drugs : 41 - (DrugBank : 22) / Drug target genes : 26 - Drug target pathways : 115
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
231. Alpha-1-antitrypsin deficiency
Clinical trials : 107 / Drugs : 88 - (DrugBank : 17) / Drug target genes : 36 - Drug target pathways : 50
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
298. Hereditary pancreatitis
Clinical trials : 110 / Drugs : 142 - (DrugBank : 59) / Drug target genes : 61 - Drug target pathways : 154
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|